FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States

• Alberto E. Paniz-Mondolfi ,

  * E-mail: alberto.paniz-mondolfi@mountsinai.org

  Affiliation Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  https://orcid.org/0000-0003-1259-1736

  ⨯
• Juan David Ramírez

  Affiliation Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

  https://orcid.org/0000-0002-1344-9312

  ⨯